Different Type of Colon Cancer Vaccine Reduces Disease Spread, Jefferson Scientists Show
(Published 6-24-2008) Taking advantage of the fact that the intestines have a separate immune system from the rest of the
body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development
of metastatic disease.
Jefferson Establishes Vaccine Center
(Published 10-26-2007) After decades of pioneering research in fields ranging from melanoma and colon cancer to HIV and rabies,
vaccine researchers at Thomas Jefferson University finally have a “home” to call their own. Jefferson has established the
Jefferson Vaccine Center to create an infrastructure for all of the university’s research and clinical efforts, while hoping
to spur new collaboration and innovation.
Jefferson Researchers Find that Personalized Interventions are Key to Improving Colon Cancer Screening Rates
(Published 9-24-2007) One of the best ways to encourage an individual to get screened for colorectal cancer is to use a personalized
approach, according to researchers at the Kimmel Cancer Center at Jefferson and Jefferson Medical College in Philadelphia
. A new study shows that simple, personalized interventions that guide recipients through the screening process can significantly
improve colorectal cancer screening rates in primary care practices.
Colon Cancer a Disease of Hormone Deficiency, Jefferson Team Finds
(Published 8-1-2007) Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have found new evidence suggesting
that colon cancer is actually a disease of missing hormones that could potentially be treated by hormone replacement therapy.
Trial Supports Use of Marker to Predict How Pancreatic Cancer Patients Do After Surgery, Jefferson Surgeon Finds
(Published 6-22-2007) A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has
found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will
do after surgery, chemotherapy and radiation. The levels of the protein CA 19-9 in the blood can be used to determine the
need for further therapy, they say.
Jefferson Vaccine Pioneer Hilary Koprowski, M.D., Wins 2007 Sabin Gold Medal
(Published 5-1-2007) Hilary Koprowski, M.D., one of the world’s outstanding biomedical researchers over the last half-century,
is the 2007 winner of the Sabin Gold Medal.
Jefferson Oncologist’s Video Aimed at Raising Colorectal Cancer Awareness Among African-Americans
(Published 4-23-2007) Despite advances in research and treatment that continue to help many people live beyond a colorectal
cancer diagnosis, African-Americans are more likely to die from the disease than any other racial or ethnic group. Edith P.
Mitchell, M.D., is trying to do something about that.
Jefferson Scientists Uncover Gene Mutation that Cuts Colon Polyps, May Suppress Cancer
(Published 3-21-2007) Cancer biologists at the Kimmel Cancer Center at Jefferson have found a gene mutation that can dramatically
reduce the number of colon polyps that develop, and in turn, potentially cut the risk of cancer.
